The role of magnetic resonance imaging and spectroscopy in transplantation: From animal models to man

NMR in Biomedicine

Volumn 13, Issue 6, 2000, Pages 329-348

  Beckmann, Nicolau ^a,b   Hof, Robert P ^a   Rudin, Markus ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b WSJ 386209 ^*  (Switzerland)

Author keywords

Graft; MRI; MRS; Rejection; Transplantation

Indexed keywords

ANGIOGRAPHY; ANIMAL MODEL; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; NERVE GRAFT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY; TECHNIQUE;

ANIMAL; BONE MARROW TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, ANIMAL; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION;

ANIMALIA;

EID: 0033798938     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1492(200010)13:6<329::AID-NBM653>3.0.CO;2-W     Document Type: Review

References (116)

1. Pathology of allograft rejection
2. The detection of cardiac allograft rejection by alterations in proton NMR relaxation times
3. Cardiac transplantations in dogs: Evaluation with MR
4. MR imaging in assessment of cardiac transplant rejection in humans
5. Pitfalls in MR Measurement of tissue blood flow with intravascular tracers: Which mean transit time?
6. Analysis of tracer transit time in rat brain after carotid artery and femoral vein administrations using linear system theory
7. Renal artery stenosis: In vivo perfusion MR imaging
8. Renal perfusion in humans: MR imaging with spin tagging of arterial water
9. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency
10. Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling
11. The magnetic resonance renogram in renal transplant evaluation using dynamic contrast-enhanced MR imaging
12. Magnetic resonance renography: Optimisation of pulse sequence parameters and Gd-DTPA dose, and comparison with radionuclide renography
13. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd(DOTA) using dynamic MRI
14. Magnetic resonance imaging: A reliable test for the evaluation of proximal atherosclerotic renal arterial stenosis
15. Two and three-dimensional phase contrast MR angiography of the abdomen
16. Detection of main renal artery stenosis using phase-contrast cine MR angiography
17. MR angiography of the head and neck: Value of two dimensional phase-contrast projection technique
18. Gadolinium-enhanced MR aortagraphy
19. Signal targeting with alternating radiofrequency (STAR) sequences: Application to MR angiography
20. 31phosphorus nuclear magnetic resonance
21. 31P MRS study in pig liver
22. Localized 31P MR spectroscopy of the transplanted human kidney in situ shows altered metabolism in rejection and acute tubular necrosis
23. Proton-decoupled phosphorus-31 magnetic resonance spectroscopy in the evaluation of native and well-functioning transplanted kidneys
24. NMR spectroscopy as a novel approach to the monitoring of renal transplant function
25. Evaluation of normothermic ischemia and simple cold preservation injury in pig kidney by proton nuclear magnetic resonance spectroscopy
26. T2 relaxation time study of the pig renal allografts
27. Improvement in experimental cardiac preservation based on metabolic considerations
28. 31P magnetic resonance spectroscopy study
29. Heterogeneity of myocardial edema in isolated pig hearts after perfusion with different types of cardioprotective solutions
30. Proton spin-lattice relaxation time as liver transplantation graft viability parameter
31. Proton spin-spin relaxation times as liver transplantation graft viability parameter
32. Controlled liver splitting for transplantation in two recipients: Technique, results and perspectives
33. Controlled hepatic bipartition for transplantation in children
34. Three-dimensional reconstruction of the liver venous system using the preservation solution as contrast agent
35. 31P magnetic resonance spectroscopy in monitoring the viability of human renal grafts stored in Euro-Collins perfusion solution
36. Functional recovery after human heart transplantation is related to the metabolic condition of the hypothermic donor heart
37. 31P-magnetic resonance spectroscopy for early graft function
38. The tissue hydration state in UW-preserved human donor livers. A clinical study of the relation between proton magnetic resonance relaxation times, donor condition, preservation procedure, and early graft function
39. Pharmacology of cyclosporine (Sandimmune). IV. Pharmacological properties in vivo
40. Magnetic resonance imaging for the evaluation of rejection of a kidney allograft in the rat
41. Chronic rejection of a rat kidney allograft: Value of magnetic resonance imaging to assess the graft status and the effect of the somatostatin analogue SMS 201-995
42. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis?
43. 31P nuclear magnetic resonance study of acute renal dysfunction in rat kidney transplants
44. 31P NMR study of renal allograft rejection in the rat
45. 31P MRS: Experimental study in canines
46. The expanded scope of effectiveness of magnetic resonance imaging to determine cardiac allograft rejection
47. Assessment of cardiac rejection and immunosuppression by magnetic resonance imaging and spectroscopy
48. Magnetic resonance spectroscopy for assessing myocardial rejection in the transplanted rat heart
49. Differentiation of cardiac ischemia and rejection by nuclear magnetic spectroscopy
50. Heterotopic heart transplantation alters high-energy phosphate metabolism irrespective of cardiac allograft rejection
51. Assessment of cardiac rejection by MR-imaging and MR-spectroscopy
52. 23Na magnetic resonance spectroscopy
53. Liver transplantation: Current and potential applications of magnetic resonance spectroscopy
54. 31P localized MR spectroscopy for follow-up of liver status at different steps of orthotopic transplantation - A feasibility study
55. Acute liver rejection: Evaluation with cell-directed MR contrast agents in a rat transplantation model
56. Towards understanding the pathophysiology of chronic rejection
57. Pathogenesis and treatment perspectives of chronic graft rejection (CVR)
58. Chronic rejection-graft arteriosclerosis
59. Cellular and molecular biology of chronic rejection
60. Molecular pathology of acute and chronic rejection
61. Chronic graft loss: Dealing with the vascular alterations in solid organ transplantation
62. Mechanisms of stenosis after arterial injury
63. Importance of experimental models for the development of clinical trials on thromboatherosclerosis
64. Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery ballon cather injury in the rat
65. Pharmacological inhibition of restenosis: Learning from experience
66. The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection
67. Preclinical models of chronic rejection: Promises and pitfalls
68. Chronic rejection in rat aortic allografts: An experimental model for transplant arteriosclerosis
69. Murine model of accelerated transplant arteriosclerosis
70. Allo- and autotransplantation of carotid artery, a new model of chronic graft vessel disease: Evaluation by magnetic resonance imaging and histology
71. Enhanced graft survival in the hippocampus following selective denervation
72. Magnetic resonance imaging of intracerebral neural grafts
73. Striatal grafts in a rat model of Huntington's disease: Time course comparison of MRI and histology
74. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging
75. Differentiation of delayed kidney graft function with gadolinium-DTPA-enhanced magnetic resonance imaging and Doppler ultrasound
76. Gadolinium-enhanced magnetic resonance angiography of renal transplants
77. 31P MR spectroscopy
78. 31P-MRS) of human allografts after renal transplantation
79. Renal NMR spectroscopy
80. Assessment of renal viability by phosphorus-31 magnetic resonance spectroscopy
81. Magnetic resonance imaging of human orthotopic heart transplantation: Correlation with endomyocardial biopsy
82. Coronary artery bypass graft patency: Noninvasive evaluation with MR imaging
83. Atrial emptying with orthotopic heart transplantation using bicaval and pulmonary venous anastomoses: A magnetic resonance imaging study
84. Proton magnetic resonance spectroscopy of blood plasma in heart transplant recipients treated with cyclosporine: An early prognosis test of long-term graft tolerance
85. Comparison of dynamic contrast enhanced MRI and Doppler ultrasound in the pre-operative assessment of the portal venous system
86. Magnetic resonance of the hepatic veins with angular reconstruction: Application in living-related liver transplantation
87. Liver transplantation: Significance of the periportal collar on MRI
88. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts
89. Changes in adipose tissue composition in malnourished patients before and after liver transplantation: A carbon-13 magnetic resonance spectroscopy and gas-liquid chromatography study
90. 13C magnetic resonance spectroscopy in man
91. Vascular complications of pancreatic transplantation: MR evaluation
92. MRI is superior to angiography for evaluation of living-related simultaneous pancreas and kidney donors
93. Regional distribution of lung perfusion and ventilation at rest and during steady-state exercise after unilateral lung transplantation
94. Pulmonary perfusion: Qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion-recovery turbo FLASH
95. Lung perfusion demonstrated by contrast-enhanced dynamic magnetic resonance imaging. Application to unilateral lung transplantation
96. 129Xe
97. Human lung air spaces: Potential for MR imaging with hyperpolarized He-3
98. Normal and abnormal pulmonary ventilation: Visualization at hyperpolarized He-3 MR imaging
99. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging
100. Pulmonary and aortic blood flow measurements in normal subjects and patients after single lung transplantation at 0.5 T using velocity encoded cine MRI
101. 31P-MRS
102. MRI in the evaluation of late bone marrow changes following bone marrow transplantation
103. Localized MR 1H spectroscopy reveals alterations of susceptibility in bone marrow with hemosiderosis
104. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy
105. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation
106. Safety of intrastriatal neurotransplantation for Huntington's disease patiens
107. MRI-stereotactical approach for neural grafting in basal ganglia disorders
108. In vivo magnetic resonance spectroscopy of human fetal neural transplants
109. Transesophageal echocardiographic assessment of pulmonary venous flow after single lung transplantation
110. Sequential CT in monitoring experimental lung transplant
111. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging
112. In vivo magnetic resonance imaging and spectroscopy in pharmaceutical research: Assessment of morphological, physiological and metabolic effects of drugs
113. In Vivo magnetic resonance methods in pharmaceutical research: Current status and perspectives
114. A comparative study between ultrasonography, magnetic resonance imaging and histology for the assessment of a chronic renal allograft rejection model in the rat